David A. Karanian, Ph.D.

University of Connecticut, Storrs, CT, United States 
Neuroprotection in models of Alzheimer-type pathogenesis
"David Karanian"
Mean distance: 30533.1


Sign in to add mentor
Ben A. Bahr grad student 2005 University of Connecticut
 (The endocannabinoid system: Cellular and functional protection against stroke-type brain damage.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Farizatto KLG, McEwan SA, Naidoo V, et al. (2017) Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon. Journal of Molecular Neuroscience : Mn
Naidoo V, Karanian DA, Vadivel SK, et al. (2012) Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 801-13
Naidoo V, Nikas SP, Karanian DA, et al. (2011) A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity. Journal of Molecular Neuroscience : Mn. 43: 493-502
Williams J, Wood J, Pandarinathan L, et al. (2007) Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Analytical Chemistry. 79: 5582-93
Karanian DA, Karim SL, Wood JT, et al. (2007) Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. The Journal of Pharmacology and Experimental Therapeutics. 322: 1059-66
Kosten TA, Karanian DA, Yeh J, et al. (2007) Memory impairments and hippocampal modifications in adult rats with neonatal isolation stress experience. Neurobiology of Learning and Memory. 88: 167-76
Butler D, Bendiske J, Michaelis ML, et al. (2007) Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. European Journal of Pharmacology. 562: 20-7
Karanian DA, Bahr BA. (2006) Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Current Molecular Medicine. 6: 677-84
Karanian DA, Baude AS, Brown QB, et al. (2006) 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Hippocampus. 16: 834-42
Bahr BA, Karanian DA, Makanji SS, et al. (2006) Targeting the endocannabinoid system in treating brain disorders. Expert Opinion On Investigational Drugs. 15: 351-65
See more...